Jay Hancock

Jay Hancock was a senior correspondent for KFF Health News until he retired in Feburary 2022.

jayhancock@protonmail.com
@JayHancock1

Covid Expert Joins Exodus Into Business, Where Science Parlays Into Profits

KFF Health News Original

Like others in academia or government who’ve served as public health advisers during the pandemic, Dr. Michael Mina traded his university role for a commercial venture. He recently took a top job at eMed, a startup that charges a premium price for monitoring at-home covid tests. Can experts do well by trying to do good?

An $80,000 Tab for Newborns Lays Out a Loophole in the New Law to Curb Surprise Bills

KFF Health News Original

The insurance company said that the birth of the Bull family’s twins was not an emergency and that NICU care was “not medically necessary.” The family’s experience with a huge bill sent to collections happened in 2020, but it exposes a hole in the new No Surprises law that took effect Jan. 1.

As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him

KFF Health News Original

President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.